Ruchit A Shah1, Vijayakumar Subban2, Anitha Lakshmanan3, Srinivasan Narayanan4, Kalaichelvan Udhayakumaran2, Balaji Pakshirajan2, Jaishankar Krishnamoorthy5, Kalidass Latchumanadhas5, Ezhilan Janakiraman5, Ajit S Mullasari6. 1. Consultant, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India. Electronic address: drruchitshah@gmail.com. 2. Consultant, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India. 3. Physician Assistant, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India. 4. Resident in Cardiology, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India. 5. Senior Consultant, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India. 6. Director, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India.
Abstract
AIM: To evaluate the safety and efficacy of various initial strategies of loop diuretic administration in patients with acute decompensated heart failure (ADHF) on diuresis, renal function, electrolyte balance and clinical outcomes. METHODS:Consecutive patients admitted with ADHF were randomized into three groups - intravenous furosemide infusion + intravenous dopamine, intravenous furosemide bolus in two divided doses and intravenous furosemide continuous infusion alone. At 48 h, the treating physician could adjust the diuretic strategy. Primary endpoint was negative fluid balance at 24 h after admission. Secondary end points were duration of hospital stay, negative fluid balance at 48, 72, 96 h, the trend of serum electrolytes, and renal function and 30 day clinical outcome (death and emergency department visits). RESULTS:Overall ninety patients (thirty in each group) were included in the study. There was a greater diuresis in first 24 h (p = 0.002) and a shorter hospital stay (p = 0.023) with the bolus group. There was no significant difference in renal function and serum sodium and serum potassium levels. There was no difference in the number of emergency department visits among the three groups. CONCLUSION: All three modes of diuretic therapies can be practiced with no difference in worsening of renal function and electrolyte levels. Bolus dose administration with its rapid volume loss and shorter hospital stay might be a more effective diuretic strategy.
RCT Entities:
AIM: To evaluate the safety and efficacy of various initial strategies of loop diuretic administration in patients with acute decompensated heart failure (ADHF) on diuresis, renal function, electrolyte balance and clinical outcomes. METHODS: Consecutive patients admitted with ADHF were randomized into three groups - intravenous furosemide infusion + intravenous dopamine, intravenous furosemide bolus in two divided doses and intravenous furosemide continuous infusion alone. At 48 h, the treating physician could adjust the diuretic strategy. Primary endpoint was negative fluid balance at 24 h after admission. Secondary end points were duration of hospital stay, negative fluid balance at 48, 72, 96 h, the trend of serum electrolytes, and renal function and 30 day clinical outcome (death and emergency department visits). RESULTS: Overall ninety patients (thirty in each group) were included in the study. There was a greater diuresis in first 24 h (p = 0.002) and a shorter hospital stay (p = 0.023) with the bolus group. There was no significant difference in renal function and serum sodium and serum potassium levels. There was no difference in the number of emergency department visits among the three groups. CONCLUSION: All three modes of diuretic therapies can be practiced with no difference in worsening of renal function and electrolyte levels. Bolus dose administration with its rapid volume loss and shorter hospital stay might be a more effective diuretic strategy.
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Margaret R Thomson; Jean M Nappi; Steven P Dunn; Ian B Hollis; Jo E Rodgers; Adrian B Van Bakel Journal: J Card Fail Date: 2010-01-06 Impact factor: 5.712
Authors: Emad F Aziz; Carlos L Alviar; Eyal Herzog; Juan Pablo Cordova; Joseph H Bastawrose; Chaithanya K Pamidimukala; Andre Tojino; Terrence S Park; Dan Musat; Marrick Kukin Journal: Hellenic J Cardiol Date: 2011 May-Jun
Authors: G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor Journal: N Engl J Med Date: 2011-03-03 Impact factor: 91.245
Authors: Tiziana Bove; Alessandro Belletti; Alessandro Putzu; Simone Pappacena; Giuseppe Denaro; Giovanni Landoni; Sean M Bagshaw; Alberto Zangrillo Journal: PLoS One Date: 2018-04-24 Impact factor: 3.240
Authors: Bart Hiemstra; Geert Koster; Jørn Wetterslev; Christian Gluud; Janus C Jakobsen; Thomas W L Scheeren; Frederik Keus; Iwan C C van der Horst Journal: Acta Anaesthesiol Scand Date: 2018-12-04 Impact factor: 2.105